A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Phase 2 Study · BMS-986504 · MTAP-deleted Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Maria P Morelli, MD) · giclinicaltrials@mdanderson.org · 713-745-1297
Contact: Principal Investigator (Maria P Morelli, MD)

Study leads

Maria P Morelli, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients

Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Shanhai, China

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Cancer · Tumor, Solid · Malignant Neoplasm

Abroad (travel likely)RecruitingPHASE1, PHASE2

Austin, United States · Irving, United States

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

Ovarian Cancer Recurrent

IsraelRecruitingPHASE1, PHASE2

New Haven, United States · Louisville, United States

A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)

Neoplasms, Endometrial

Abroad (travel likely)RecruitingPHASE2

Jinan, China